Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,458
Total Claims
$542K
Drug Cost
761
Beneficiaries
$712
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+51%
Opioid rate vs peers
69.4% vs 45.9% avg
+47%
Cost per patient vs peers
$712 vs $483 avg
+92%
Brand preference vs peers
7.9% vs 4.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
69.4%
Opioid Rate
5,866
Opioid Claims
$389K
Opioid Cost
19.7%
Long-Acting Rate
This provider's opioid prescribing rate of 69.4% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 672 claims · $285K
Generic: 7,786 claims · $257K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 77 | $60K |
| Oxycodone Hcl | 71 | $55K |
| Oxycodone Hcl | 1,927 | $53K |
| Buprenorphine Hcl | 52 | $47K |
| Hydrocodone/Acetaminophen | 1,300 | $43K |
| Onabotulinumtoxina | 29 | $35K |
| Rimegepant Sulfate | 20 | $32K |
| Oxycodone Hcl/Acetaminophen | 713 | $30K |
| Fentanyl | 273 | $27K |
| Buprenorphine | 43 | $11K |
| Morphine Sulfate | 440 | $11K |
| Pregabalin | 205 | $10K |
| Hydromorphone Hcl | 441 | $8,245 |
| Naloxegol Oxalate | 17 | $7,947 |
| Gabapentin | 540 | $7,562 |
Prescribing Profile
49
Unique Drugs
26.0
Anomaly Score
Patient Profile
66
Avg Age
63%
Female
1.69
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About